1-1 of 1
Feilan Wang, PhD
Close
Sort by
Journal Articles

Preclinical Evaluation of MAX-40279, a FLT3/FGFR Dual Kinase Inhibitor for Treatment of Acute Myeloid Leukemia

Yuguang Wang, PhD, Hanying Bao, MD PhD, Nong Zhang, PhD, Feilan Wang, PhD, Yunsong He, MD, Tianzhi Wu, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3997.
https://doi.org/10.1182/blood-2018-99-110414
Published: 2018